iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS)

CUSIP: 46565G104

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
10,000
Total 13F shares
34,550,470
Share change
-442,384
Total reported value
$471,199,415
Put/Call ratio
38%
Price per share
$13.64
Number of holders
128
Value change
-$28,496
Number of buys
50
Number of sells
73

Quarterly Holders Quick Answers

What is CUSIP 46565G104?
CUSIP 46565G104 identifies ITOS - iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q1 2024

As of 31 Mar 2024, iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) was held by 128 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,550,470 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., MPM ASSET MANAGEMENT LLC, EcoR1 Capital, LLC, Boxer Capital, LLC, MPM BIOIMPACT LLC, MORGAN STANLEY, VANGUARD GROUP INC, CITADEL ADVISORS LLC, and BRAIDWELL LP. This page lists 129 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.